Publication: 3020

Publication: 3020

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 37 (21) 1790-1799

Year:: 2019
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:: Previous presentation of the manuscript; American Society of Hematology Annual Meeting, December 2016

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 8

Parents:: 2569
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U10CA180847, U10CA180833, U10CA180799, U10CA180820, U24CA196171

Corr. Author:
Authors:: Nancy L. Bartlett Wyndham H. Wilson Sin-Ho Jung Eric D. Hsi Matthew J. Maurer Levi D. Pederson Mei-Yin C. Polley Brandelyn N. Pitcher Bruce D. Cheson Brad S. Kahl Jonathan W. Friedberg Louis M. Staudt Nina D. Wagner-Johnston Kristie A. Blum Jeremy S. Abramson Nishitha M. Reddy Jane N. Winter Julie E. Chang Ajay K. Gopal Amy Chadburn Susan Mathew Richard I. Fisher Kristy L. Richards Heiko Schöder Andrew D. Zelenetz John P. Leonard

Networks:: CAPITAL, CORA, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, LAPS-TN008, LAPS-WI020, NY018, PA121

Study: CALGB-50303
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: RAPID COMMUNICATION, Lymphoma and Myeloma